Navigation Links
Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
Date:1/8/2008

Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning HYLENEX clinical trial results) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Halozyme Contact Media Contacts

David A. Ramsay Karen Sparks / Joleen Schultz

Chief Financial Officer Mentus

(858) 704-8260 (858) 455-5500, x275/x215

dramsay@halozyme.com karen@mentus.com

jschultz@mentus.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
2. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
3. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
4. Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
5. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
6. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium
9. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
10. Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
11. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PRNewswire/--Reportlinker.comannouncesthatanewmark... PainManagement-GlobalTrends ,, http://www.r...Trends.html ,, Widespreadavailabilityofgeneric...tofnewdrugshaveacceleratedthepaceofgrowthinthepain...structurecontinuetoshapedemandforservices,drugsand...
(Date:11/25/2009)...lif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,annou...,sPROTECT-1(theProspectiveRandomizedOralTherapyEva...282-B)inpatientswithmoderate-to-severeCrohn,sdisea...andtolerabilityprofile.Thestudydemonstratedevidenc...asdefinedasa70-pointdecreaseintheCrohn,sDiseaseAct...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--QuestDiagnosticsIncorp...nostictesting,informationandservices,announcedthat...lthcareConferenceinNewYorkCity.Thepresentationissc...nTime. ,, Duringtheconference,thecompanywillrea...%,operatingincometoexceed18%ofrevenues,anddilutede...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 48027 1Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 48027 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 1Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 2
(Date:11/25/2009)...,Nov.25()/PRNewswire-FirstCall/--ErnestB.Remo,Chai...(PinkSheets:ADHC),announcedtodaythatitsnewwebsitew...linginvestorstoeasilyaccesstimelyinformationandsig...sedat: http://www.americandiversifiedholdings.com ...ewwebsiteallowsustoproviderelevantinformationtosha...
(Date:11/25/2009)... across the globe have come together to form the I... is to mobilise health professionals across the wo...hange. , The Council will be officially launched...series of papers being published by the Lancet o... greenhouse gas emissions, ahead of the UN Climate...
(Date:11/25/2009)...rican medicinal herb proves effective in animal st...ws) -- An herb called Brazilian mint treats pain a...earchers report. , Traditional healers in Brazi...t a range of health problems, including headaches,...rst to scientifically prove the pain-relieving pro...
(Date:11/25/2009)...mbers can panic, underestimate effects of normal ...News) -- Thanksgiving is a time of eating turkey, ... elderly loved one to the emergency room. , Acc...hen family members who have not seen each other in... often alarmed by the health of their older relati...
(Date:11/25/2009)...Nov.25/PRNewswire/--IntroducingPariBeautyProfessio...dvancedskincarededicatedtoprovidingprestigeformula...restigeskincareandcolorcosmeticbrandtolaunchunderM...fficesinSanFranciscoandToronto,wasfoundedandismana...thover35yearsexperienceintheindustry.PariBeautywil...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces New Website 2Health News:Senior doctors launch global movement to tackle climate change 2Health News:ER Visits for Elderly Rise During Thanksgiving 2Health News:ER Visits for Elderly Rise During Thanksgiving 3Health News:Pari Beauty Professional Artistry 2
...le MD Four researchers under age 45 have been nam...ative Ophthalmology Research Award (IORA) for thei...he awards are worth a total of $70,000 for the res...utstanding young researchers under 45 every other ...
... , , , , , , , ... , , , VIDEO: , MSU che... make anti-cancer drug paciltaxel. , , ... EAST LANSING, Mich. --- Research by Michigan Stat...
... Wash., April 2 SCOLR Pharma, Inc. (NYSE Alternex...hPro BioVentures LLC ("HealthPro"), a life science...its financial advisor in connection with the evalu...ur team. This is an important step in our continu...
...RG, Pa., April 2 With a boost from state investme... its world headquarters to York County in an $8.7 ...-wage jobs, Governor Rendell announced today. , ,...nilife will manufacture innovative healthcare safe...
...y compiles comparison of therapies for both doctor...lthDay News) -- New "plain language" guides from t...tween available treatments for type 2 diabetes for...lin analogues to conventional insulin (human insul...
...es emphasize reforms that support economic opportu... a bipartisan coalition of business, civic and pol...a for an Opportunity Economy," a core set of refor...omy, accounting for almost 25 percent of all econo...
Other Medicine News:Health News:Young eye researchers receive prestigious ARVO-AFER/Merck award 2Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 2Health News:'Green chemistry' could ease manufacture, boost usefulness of cancer drug 3Health News:SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor 2Health News:Governor Rendell Lauds Arrival of Medical Device Firm's Global Headquarters in York County 2Health News:Governor Rendell Lauds Arrival of Medical Device Firm's Global Headquarters in York County 3Health News:Plain-Language Guides Detail Insulin Treatments 2Health News:Diverse, Bipartisan Health Care Reform Voices Announce Agreement on Key Principles 2Health News:Diverse, Bipartisan Health Care Reform Voices Announce Agreement on Key Principles 3
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: